Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Yaz (drospirenone/ethinyl estradiol) for Oral Contraception and Premenstrual Dysphoric Disorder
Company: Berlex, Inc.
NDA: 021873
Approval Date: 10/4/2006


Date created: October 3, 2008

Updated: September 22, 2011

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.